Acute and "chronic" phase reaction - A mother of disease

Clinical Nutrition

Volumn 23, Issue 6, 2004, Pages 1256-1266

  Bengmark, Stig ^a  

^a UNIVERSITY COLLEGE LONDON   (United Kingdom)

Author keywords

Abdominal obesity; Acute phase response; Alzheimer disease; Arteriosclerosis; Breast cancer; Cancer; Cellular membranes; Chronic locomotor disease; Chronic phase response; Chronic renal disease; Cirrhosis; Colorectal cancer; Coronary vascular diseases; Crohn's disease; Diabetes; Endothelial cells; Fatty liver; Free fatty acids; Gallbladder disease; Gout; Growth hormones; Inflammatory bowel disease; Insulin resistance; Irritable bowel syndrome; Metabolic syndrome; Neurodegenerative diseases; Parkinson disease; Polycystic ovary syndrome; Prostatic cancer; Rheumatoid arthritis; Ulcerative colitis

Indexed keywords

ANTIOXIDANT; CYTOKINE; FATTY ACID; SATURATED FATTY ACID; STARCH; SUGAR;

ACUTE PHASE RESPONSE; ADIPOCYTE; CELL FUNCTION; CELL MEMBRANE; CHRONIC DISEASE; CYTOKINE RELEASE; ENDOTHELIUM CELL; EXERCISE; FOOD INTAKE; FRUIT; HUMAN; IMMUNE SYSTEM; LIFESTYLE; MENTAL STRESS; METABOLIC SYNDROME X; MORBIDITY; MORTALITY; NUTRIENT; PHYSICAL STRESS; REVIEW; STRESS; VEGETABLE;

ACUTE-PHASE REACTION; ADIPOSE TISSUE; AGING; CHRONIC DISEASE; DIET; ENDOTHELIAL CELLS; EXERCISE; HUMANS; LIFE STYLE; METABOLIC SYNDROME X; STRESS;

EID: 8744222484     PISSN: 02615614     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.clnu.2004.07.016     Document Type: Review

References (109)

1. L.B. Schook L. Carrick Jr. R.S. Berk et al. Murine gastrointestinal tract as a portal of entry in experimental Pseudomonas aeruginosa infections Infect Immun 14 1976 564-570
2. P. Brandtzaeg T.S. Halstensen K. Kett et al. Immunobiology and immunopathology of human gut mucosa, humoral immunity and intraepithelial lymphocytes Gastroenterology 97 1989 1562-1584
3. S. Bengmark Nutritional modulation of acute and "chronic" phase response Nutrition 17 2001 489-495
4. T. Preston C. Slater D.C. McMillan et al. Fibrinogen synthesis is elevated in fasting cancer patients with an acute phase response J Nutr 128 1998 1355-1360
5. S.N. Meydani M.S. Santos D. Wu M.G. Hayek Antioxidant modulation of cytokines and their biologic function in the aged Z Ernährungswiss 37 suppl 1 1998 S35-S42
6. L.A. Bazzano J. He L.G. Ogden et al. Dietary intake of folate and risk of stroke in US men and women Stroke 33 2002 1183-1189
7. L.T. Frame R.W. Hart J.E.A. Leakey et al. Caloric Restriction as a Mechanism Mediating Resistance to Environmental Disease Environ Health Perspect 106 1998 313-324
8. R.A. Cooper Abnormalities of cell-membrane fluidity in the pathogenesis of disease, Seminars in medicine of the Beth Israel Hospital Boston 297 1977 371-377
9. H.P. Kohler P.J. Grant Plasminogen-activator inhibitor type 1 and coronary artery disease N Engl J Med 342 2000 1792-1801
10. Haugaard SB, Andersen O, Storgaard H, et al. Insulin secretion in lipodystrophic HIV-infected patients is associated with high levels of non-glucose secretagogues and insulin resistance of beta-cells. Am J Physiol Endocrinol Metab 2004 May 18 [Epub ahead of print]
11. M.C. Alessi F. Peiretti et al. Production of plasminogen activator inhibitor 1 by human adipose tissue. Possible link between visceral fat accumulation and vascular disease Diabetes 46 1997 860-867
12. S.K. Fried D.A. Bunkin A.S. Greenberg Omental and subcutaneous adipose tissues of obese subjects release interleukin-6: Depot difference and regulation by glucocorticoid J Clin Endocrinol Metabol 83 1998 840-847
13. E.L. Thomas N. Saeed J.V. Hajnal et al. Magnetic resonance imaging of total body fat J Appl Physiol 85 1998 1778-1785
14. J. Genesca A. Gonzalez et al. Interleukin-6, nitric oxide, and the clinical and haemodynamic alterations of patients with liver cirrhosis Am J Gastroenterol 94 1999 169-177
15. M. Cigolini G. Targher G. Agostino et al. Liver steatosis and its relation to plasma haemostatic factors in apparently healthy men-role of the metabolic syndrome Thromb Haemost 76 1996 69-73
16. W.B. Kannel R.B. D'Agostino P.W. Wilson et al. Diabetes, fibrinogen and risk of cardiovascular disease. The Framington experience Am Heart J 120 1990 672-676
17. B.E. Sobel The potential influence of insulin and plasminogen activator inhibitor type 1 on the formation of vulnerable artheriosclerotic plaques associated with type 2 diabetes Proc Asso Amer Physicians 111 1999 313-318
18. A.D. Pradhan J.E. Manson N. Rifai et al. C-reactive protein, interleukin 6, and risk of developing type 2 diabetes mellitus JAMA 286 2001 327-334
19. D.M. Steel A.S. Whitehead The major acute phase reactants: C-reactive protein, serum amyloid P component and serum amyloid A protein Immunol Today 15 1994 81-88
20. R. Mortensen Macrophages and acute phase proteins in: B. Zwilling T. Eisenstein eds. Macrophage-pathogen interactions 1994 Marcel Dekker New york 143-158
21. J.C. Pickup M.A. Crook Is type II diabetes mellitus a disease in the innate immune system Diabetologia 41 1998 1241-1248
22. B.B. Duncan M.I. Schmidt Chronic activation of the innate immune system may underlie the metabolic syndrome Sao Paulo Med J 119 2001 122-127
23. D.M. Wilson L.I. Binder Free fatty acids stimulate the polymerization of tau and amyloid β peptides-in vitro evidence for a common effector of pathogenesis in Alzheimer's disease Am J Pathol 150 1997 2181-2195
24. G.M. Reaven C. Hollenbeck C.U. Jeng et al. Measurement of plasma glucose, free fatty acid, lactate and insulin for 24 h in patients with NIDDM Diabetes 37 1988 1020-1024
25. T. Stulnig M. Berger M. Roden et al. Elevated free fatty acid concentrations inhibit T lymphocyte signaling FASEB J 14 2000 939-947
26. R.E. Brown R.W. Steele D.J. Marmer et al. Fatty acids and the inhibition of mitogen-induced lymphocyte transformation by leukemic serum J Immunol 131 1983 1011-1016
27. A. Legaspi M. Jeevanandam H.F. Starnes et al. Whole body energy metabolism in the cancer patient Metabolism 36 1987 958-963
28. S.C. Hendrickson J.D. St Louis J.E. Lowe et al. Free fatty acid metabolism during myocardial ischemia and reperfusion Mol Cell Biochem 166 1997 85-94
29. J. Lommi M. Kupari H. Yki-Jarvinen Free fatty acid kinetics and oxidation in congestive heart failure Am J Cardiol 81 1998 45-50
30. G. Meininger C. Hadigan M. Laposata et al. Elevated concentrations of free fatty acids are associated with increased insulin response to standard glucose challenge in human immunodeficiency virus-infected subjects with fat redistribution Metabolism 51 2002 260-266
31. C. Hadigan S. Borgonha J. Rabe et al. Increased rates of lipolysis among human immunodeficiency virus-infected men receiving highly active antiretroviral therapy Metabolism 51 2002 1143-1147
32. D. Vannoni L. Ciccoli R. Leoncini et al. Fatty acid composition of plasma lipids in gout Biomed Pharmacother 40 1986 348-351
33. Y. Nishida I. Akaoka T. Nishizawa T. Yoshimura Hyperlipidaemia in gout Clin Chim Acta 62 1975 103-106
34. V. Nehra P. Angulo A.L. Buchman et al. Nutritional and metabolic considerations in the etiology of nonalcoholic steatohepatitis Dig Dis Scien 46 2001 2347-2352
35. B. Rutkowski L. Tylicki J. Manitius W. Lysiak-Szydlowska Hypertensive nephropathy-an increasing clinical problem Miner Electrolyte Metab 25 1999 65-68
36. L. Lind H. Lithell Impaired glucose and lipid metabolism seen in intensive care patients is related to severity of illness and survival Clin Intens Care 5 1994 100-105
37. W.C. Willett M.J. Stampfer J.E. Manson et al. Intake of trans fatty acids and risk of coronary heart disease among women Lancet 341 1993 581-585
38. C.M. Oomen M.C. Ocke E.J. Feskens et al. Association between trans fatty intake and 10-year risk of coronary heart disease in the Zutphen elderly study: A prospective population-based study Lancet 357 2001 746-751
39. R.N. Lemaitre I.B. King T.E. Raghunathan et al. Cell membrane trans-fatty acids and the risk of primary cardiac arrest Circulation 105 2002 697-701
40. A.M. Katz Trans-fatty acids and sudden cardiac death Circulation 105 2002 669-701
41. J. Salmeron F.B. Hu J.E. Manson M.J. Stampfer et al. Dietary fat intake and risk of type 2 diabetes in women Am J Clin Nutr 73 2001 1019-1026
42. P. Liuba P. Karnani E. Pesonen et al. Endothelial dysfunction after repeated Chlamydia pneumoniae infection in apolipoprotein E-knockout mice Circulation 102 2000 1039-1044
43. M.F. McCarty Does postprandial storage of triglycerides in endothelial cells contribute to the endothelial dysfunction associated with insulin resistance and fatty diets? Med Hypotheses 61 2 2003 167-172
44. F.S. Facchini N. Hua F. Abbasi G.M. Reaven Insulin resistance as a predictor of age-related diseases J Clin Endocrin Metab 86 2001 3574-3578
45. H. Bruunsgaard M. Pedersen B.K. Pedersen Aging and proinflammatory cytokines Curr Opin Hematol 8 2001 131-136
46. H. Bruunsgaard Effects of tumor necrosis factor-alpha and interleukin-6 in elderly populations Eur Cytokine Netw 13 2002 387-392
47. J.W. Rowe R.L. Kahn Human aging: Usual and successful Science 237 1987 143-149
48. P. Caprari A. Scuteri A.M. Salvati Aging and red blood cell membrane: A study in centenarians Exp. Gerontolog 34 1999 47-57
49. G.S. Watson S. Craft The role of insulin resistance in the pathogenesis of Alzheimer's disease implications for treatment CNS Drugs 17 2003 27-45
50. S.T. Henderson High carbohydrate diets and Alzheimer's disease Med Hypotheses 62 2004 689-700
51. D.M. Wilson L.I. Binder Free fatty acids stimulate the polymerization of tau and amyloid beta peptides. In vitro evidence for a common effector of pathogenesis in Alzheimer's disease Am J Pathol 150 1997 2181-2195
52. M.P. Mattson W.A. Pedersen W. Duan et al. Cellular and molecular mechanisms underlying perturbed energy metabolism and neuronal degeneration in Alzheimer's and Parkinson's diseases Ann NY Acad Sci 893 1999 154-175
53. M.R. Prasad M.A. Lovell M. Yatin et al. Regional membrane phospholipid alterations in Alzheimer's disease Neurochem Res 23 1998 81-88
54. S. Schippling A. Kontush S. Arlt et al. Increased lipoprotein oxidation in Alzheimer's disease Free Radic Biol Med 28 2000 351-360
55. R. Clarke A.D. Smith K.A. Jobst et al. Folate, vitamin B12, and serum total homocysteine levels in confirmed Alzheimer disease Arch Neurol 55 1998 1449-1455
56. W. Reynish S. Andrieu F. Nourhashemi B. Vellas Nutritional factors and Alzheimer's disease J Gerontol 54A 2001 M675-M680
57. G. Camejo U. Olsson E. Hurt-Camejo et al. The extracellular matrix on atherogenesis and diabetes-associated vascular disease Atheroscler 3 suppl 2002 3-9
58. R.A. Vogel M.C. Corretti G.D. Plotnick Effect of a single high-fat meal on endothelial function in healthy subjects Am J Cardiol 79 1997 350-354
59. L. Liu S.P. Zhao M. Gao et al. Vitamin C preserves endothelial function in patients with coronary heart disease after a high-fat meal Clin Cardiol 25 2002 219-224
60. K. Dunder L. Lind B. Zethelius et al. Increase in blood glucose concentration during antihypertensive treatment as a predictor of myocardial infarction: Population based cohort study Br Med J 326 2003 680-681
61. D.B. Corry M.L. Tuck Selective aspects of the insulin resistance syndrome Curr Opin Nephrol Hypertens 10 2001 507-514
62. B.A. Stoll Upper abdominal obesity, insulin resistance and breast cancer risk Int J Obesity 26 2002 747-753
63. M. Jain A.B. Miller T. To Premorbid diet and the prognosis of women with breast cancer J Natl Cancer Inst 86 1994 390-1397
64. L.E. Holm E. Nordevang M.L. Hjalmar et al. Treatment failure and dietary habits in woman with breast cancer J Natl Cancer Inst 85 1993 32-36
65. M. Pollak Insulin-like growth factor physiology and cancer risk Eur J Cancer 36 2000 1224-1228
66. E. Giovannucci Insulin, insulin-like growth factors and colon cancer, a review of the evidence J Nutr 131 suppl. 2001 S3109-S3120
67. H. Yu R. Rohan Role of insulin-like growth factor family in cancer development and progression J Natl Cancer Inst 92 2000 1472-1489
68. J.L. Outwater A. Nicholson N. Barnard Dairy products and breast cancer, The IGF-1, estrogen and bGH hypothesis Med Hypotheses 48 1997 453-461
69. M.D. Holmes M.N. Pollak W.C. Willett S.E. Hankinson Dietary correlates of plasma insulin-like growth factor I and insulin-like growth factor binding protein 3 concentrations Cancer Epidemiol Biomarkers Prev 11 2002 852-861
70. A.D. Pradhan J.E. Manson N. Rifai et al. C-reactive protein, burden trough 2050: Impact of changing demography and disease prevalence in the US Diabetes Care 24 2001 1936-1940
71. J.P. Boyle A.A. Honeycutt K.M. Narayan et al. Projection of diabetes malnutrition, inflammation, and atherosclerosis (MIA) syndrome-the heart of the matter Nephrol Dial Transplant 17 suppl 2002 11:S28-11:S31
72. R.K.R. Scragg C.D. Carvert J.R. Oliver Plasma lipids and insulin in gallstone disease: A controlled study Br Med J 289 1984 521-525
73. A.K. Diehl Cholelithiasis and the insulin resistance syndrome Hepatology 31 2000 528-530
74. R. de Marco F. Locatelli G. Zoppini et al. Causae-pecific mortality in type 2 diabetes. The Verona diabetes study Diabetes Care 22 1999 756-761
75. S. Bengmark Liver steatosis and liver resection Digestion 2 1969 304-311
76. G. Marchesini G. Forlani NASH: From liver diseases to metabolic disorders and back to clinical hepatology Hepatology 35 2002 497-499
77. J.B. Dixon P.S. Bhathal P.E. O'Brien Non-alcoholic fatty liver disease in the severely obese Gastrenterology 121 2001 91-100
78. I. Tavares De Almeida H. Cortes-Pinto G. Fidalgo et al. Plasma total and free fatty acids composition in human non-alcoholic steatohepatitis Clin Nutr 21 2002 219-223
79. D. Fliser G. Pacini R. Engelleiter et al. Insulin resistance and hyperinsulinemia are already present in patients with incipient renal disease Kidney Int 53 1998 1343-1347
80. A. Irish Cardiovascular disease, fibrinogen and the acute phase response, Association with lipids and blood pressure in patients with chronic renal disease Atherosclerosis 53 1998 1343-1347
81. R. Pecoits-Filho B. Lindholm P. Stenvinkel et al. The interleukin 6 and risk of developing type 2 diabetes mellitus JAMA 286 2001 327-334
82. P. Stenvinkel C. Wanner T. Metzger et al. Inflammation and outcome in end-stage renal failure: Does female gender constitute a survival advantage? Kidney Int 62 2002 1791-1798
83. K.L. Tucker H. Chen M.T. Hannan et al. Bone mineral density and dietary patterns in older adults. The Framington osteoporosis study Am J Clin Nutr 76 2002 245-252
84. S. Takehashi Y. Moriwaki Z. Tsutsumi et al. Increased visceral fat accumulation further aggravates the risk of insulin resistance in gout Metabolism 50 2001 393-398
85. H. Demir F. Kelestimur M. Tunc et al. Hypothalamo-pituitary-adrenal axis and growth hormone axis in patients with rheumatoid arthritis Scand J Rheumatol 28 1999 41-46
86. K.L.G. Svensson T.H. Pollare H. Lithell R. Hällgren Impaired glucose handling in active rheumatoid arthritis: Relationship to peripheral insulin resistance Metabolism 37 1988 125-130
87. P.H. Dessein B.I. Joffe A. Stanwix et al. The acute phase response does not fully predict the presence of insulin resistance and dyslipidemia in inflammatory arthritis J Rheumatol 29 2002 462-466
88. T.B. Larsen J.N. Nielsen L. Fredholm et al. Platelets and anticoagulant capacity in patients with inflammatory bowel disease Pathophysiol Haemost Thromb 32 2002 92-96
89. L.T. Bjerregaard N.J. Nederby L. Fredholm et al. Hyperhomocysteinaemia, coagulation pathway activation and thrombophilia in patients with inflammatory bowel disease Scand J Gastroenterol 37 2002 62-67
90. M.R. Corkins A.D. Gohil J.F. Fitzgerald The insulin-like growth factor axis in children with inflammatory bowel disease J Pediatr Gastroenterol Nutr 36 2003 228-234
91. E.M. Zimmermann L. Li Y.T. Hou et al. Insulin-like growth factor I and insulin-like growth factor binding protein 5 in Crohn's disease Am J Physiol Gastrointest Liver Physiol 280 2001 G1022-G1029
92. I.C. Lawrance L. Maxwell W. Doe Inflammation location, but not type, determines the increase in TGF-beta1 and IGF-1 expression and collagen deposition in IBD intestine Inflamm Bowel Dis 7 2001 16-26
93. E. Capristo G. Mingrone G. Addolorato et al. Glucose metabolism and insulin sensitivity in inactive inflammatory bowel disease Aliment Pharmacol Ther 13 1999 209-217
94. G. Loverro F. Lorusso L. Mei et al. The plasma homocystein levels are increased in polycystic ovary syndrome Gynecol Obstet Invest 53 2002 157-162
95. C.J.G. Kelly H. Lyall J.R. Petrie et al. A specific elevation of tissue plasminogen activator antigen in woman with polycystic ovarian syndrome J Clin Endocrinol Metab 87 2002 3287-3290
96. F. Gonzalez K. Thusu E. Abdel-Rahman et al. Elevated serum levels of tumor necrosis factor alpha in normal-weight women with polycystic ovary syndrome Metabolism 48 1999 437-441
97. S. Franks Polycystic ovary syndrome N Engl J Med 333 1995 853-861
98. R.S. Legro A.R. Kunselmann A. Dunaif Prevalence and predictors of dyslipidemia in woman with polycystic ovary syndrome Am J Med 111 2001 607-613
99. R.S. Legro Polycystic ovary syndrome: The new millenium Molec Cell Endocrin 184 2001 87-93
100. L. Ibanez C. Aulesa N. Potou et al. Plasminogen activator inhibitor-1 in girls with precocious pubarche: A premenarcheal marker for polycystic ovary syndrome Pediatric Res 51 2002 244-248
101. D. Young-Hyman D.G. Schlundt L. Herman et al. Evaluation of the insulin resitance syndrome in 5- to 10-year old overweight obese African-American children Diabetes Care 24 2001 1359-1364
102. J. Hammarsten B. Högstedt N. Holthuis D. Mellström Components of the metabolic syndrome-risk factors for the development of benign prostatic hyperplasia Prostate Cancer Prostatic Dis 1 1998 157-162
103. J. Hammarsten B. Högstedt Hyperinsulinaemia as a risk factor for developing benign prostatic hyperplasia Eur Urol 39 2001 151-158
104. F.C. Lowe E. Fagelman Phytotherapy in the treatment of benign prostatic hyperplasia: An update Urology 53 1999 671-678
105. U. Hoppu M. Kalliomäki E. Isolauri Maternal diet rich in saturated fat during breastfeeding is associated with topic sensization of the infant Eur J Clin Nutr 54 2000 702-705
106. E. Kylin Studien uber das Hypertonie-Hyperglykämie-Hyperurikämiesyndrom Zentralblatt Innere Medizin 44 1923 105-126
107. H. Himsworth Diabetes mellitus: A differentiation into insulin-sensitive and insulin-insensitive types Lancet 1 1936 127-130
108. J.P. Camus Goutte, diabéte, hyperlipémi: Un trisyndrome métabolique Rev Rheumat 33 1966 10-14
109. G.M. Reaven Role of insulin resistance in human disease Diabetes 37 1988 1595-1607